APO Research
Talk to an analyst

APO RESEARCH · REPORT

EGFR Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global EGFR Antibody Industry Growth and Trends Forecast to 2032

19 December 2025102 pages

Choose your research edition.

Industry ResearchEGFR Antibody Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal EGFR Antibody Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal EGFR Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EGFR Antibody Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal EGFR Antibody Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global EGFR Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for EGFR Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for EGFR Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EGFR Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of EGFR Antibody include Atlas Antibodies, Bethyl, Bio X Cell, BioLegend, Bio-Rad, Everest Biotech, EXBIO, FineTest and Miltenyi Biotec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global EGFR Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The EGFR Antibody market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global EGFR Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to EGFR Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global EGFR Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

EGFR Antibody Market by Company

Atlas Antibodies

Bethyl

Bio X Cell

BioLegend

Bio-Rad

Everest Biotech

EXBIO

FineTest

Miltenyi Biotec

Santa Cruz Biotechnology

Merck

EGFR Antibody Segment by Type

Polyclonal

Monoclonal

EGFR Antibody Segment by Application

Immunohistochemistry

Immunofluorescence

Enzyme Linked Immunosorbent Assay

Flow Cytometry

Western Blot

Others

EGFR Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EGFR Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EGFR Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EGFR Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of EGFR Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of EGFR Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polyclonal Table 2. Major Company of Monoclonal Table 3. Global EGFR Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global EGFR Antibody Sales by Type (2021-2026) & (K Units) Table 5. Global EGFR Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global EGFR Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global EGFR Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global EGFR Antibody Price by Type (2021-2026) & (US$/Unit) Table 9. Global EGFR Antibody Sales by Type (2027-2032) & (K Units) Table 10. Global EGFR Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global EGFR Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global EGFR Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global EGFR Antibody Price by Type (2027-2032) & (US$/Unit) Table 14. North America EGFR Antibody Sales by Type (2021-2026) & (K Units) Table 15. North America EGFR Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe EGFR Antibody Sales by Type (2021-2026) & (K Units) Table 17. Europe EGFR Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific EGFR Antibody Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific EGFR Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America EGFR Antibody Sales by Type (2021-2026) & (K Units) Table 21. Latin America EGFR Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa EGFR Antibody Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa EGFR Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. EGFR Antibody Industry Trends Table 25. EGFR Antibody Industry Drivers Table 26. EGFR Antibody Industry Opportunities and Challenges Table 27. EGFR Antibody Industry Restraints Table 28. Global EGFR Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global EGFR Antibody Revenue Market Share by Company (2021-2026) Table 30. Global EGFR Antibody Sales by Company (2021-2026) & (K Units) Table 31. Global EGFR Antibody Sales Share by Company (2021-2026) Table 32. Global EGFR Antibody Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global EGFR Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global EGFR Antibody Major Company Production Sites and Headquarters Table 35. Global EGFR Antibody Company, Product Type & Application Table 36. Global EGFR Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global EGFR Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global EGFR Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global EGFR Antibody Sales by Region (2021-2026) & (K Units) Table 41. Global EGFR Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global EGFR Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global EGFR Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global EGFR Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global EGFR Antibody Sales by Region (2027-2032) & (K Units) Table 46. Global EGFR Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global EGFR Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global EGFR Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global EGFR Antibody Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global EGFR Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global EGFR Antibody Sales by Application (2021-2026) & (K Units) Table 52. Global EGFR Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global EGFR Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global EGFR Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global EGFR Antibody Price by Application (2021-2026) & (US$/Unit) Table 56. Global EGFR Antibody Sales by Application (2027-2032) & (K Units) Table 57. Global EGFR Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global EGFR Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global EGFR Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global EGFR Antibody Price by Application (2027-2032) & (US$/Unit) Table 61. North America EGFR Antibody Sales by Application (2021-2026) & (K Units) Table 62. North America EGFR Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe EGFR Antibody Sales by Application (2021-2026) & (K Units) Table 64. Europe EGFR Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific EGFR Antibody Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific EGFR Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America EGFR Antibody Sales by Application (2021-2026) & (K Units) Table 68. Latin America EGFR Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa EGFR Antibody Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa EGFR Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Atlas Antibodies Company Information Table 72. Atlas Antibodies Business Overview Table 73. Atlas Antibodies EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Atlas Antibodies EGFR Antibody Product Portfolio Table 75. Atlas Antibodies Recent Development Table 76. Bethyl Company Information Table 77. Bethyl Business Overview Table 78. Bethyl EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bethyl EGFR Antibody Product Portfolio Table 80. Bethyl Recent Development Table 81. Bio X Cell Company Information Table 82. Bio X Cell Business Overview Table 83. Bio X Cell EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Bio X Cell EGFR Antibody Product Portfolio Table 85. Bio X Cell Recent Development Table 86. BioLegend Company Information Table 87. BioLegend Business Overview Table 88. BioLegend EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. BioLegend EGFR Antibody Product Portfolio Table 90. BioLegend Recent Development Table 91. Bio-Rad Company Information Table 92. Bio-Rad Business Overview Table 93. Bio-Rad EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Bio-Rad EGFR Antibody Product Portfolio Table 95. Bio-Rad Recent Development Table 96. Everest Biotech Company Information Table 97. Everest Biotech Business Overview Table 98. Everest Biotech EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Everest Biotech EGFR Antibody Product Portfolio Table 100. Everest Biotech Recent Development Table 101. EXBIO Company Information Table 102. EXBIO Business Overview Table 103. EXBIO EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. EXBIO EGFR Antibody Product Portfolio Table 105. EXBIO Recent Development Table 106. FineTest Company Information Table 107. FineTest Business Overview Table 108. FineTest EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. FineTest EGFR Antibody Product Portfolio Table 110. FineTest Recent Development Table 111. Miltenyi Biotec Company Information Table 112. Miltenyi Biotec Business Overview Table 113. Miltenyi Biotec EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Miltenyi Biotec EGFR Antibody Product Portfolio Table 115. Miltenyi Biotec Recent Development Table 116. Santa Cruz Biotechnology Company Information Table 117. Santa Cruz Biotechnology Business Overview Table 118. Santa Cruz Biotechnology EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Santa Cruz Biotechnology EGFR Antibody Product Portfolio Table 120. Santa Cruz Biotechnology Recent Development Table 121. Merck Company Information Table 122. Merck Business Overview Table 123. Merck EGFR Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Merck EGFR Antibody Product Portfolio Table 125. Merck Recent Development Table 126. North America EGFR Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America EGFR Antibody Sales by Country (2021-2026) & (K Units) Table 128. North America EGFR Antibody Sales Market Share by Country (2021-2026) Table 129. North America EGFR Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America EGFR Antibody Sales Market Share Forecast by Country (2027-2032) Table 131. North America EGFR Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America EGFR Antibody Market Size by Country (2021-2026) & (US$ Million) Table 133. North America EGFR Antibody Market Share by Country (2021-2026) Table 134. North America EGFR Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America EGFR Antibody Market Share Forecast by Country (2027-2032) Table 136. Europe EGFR Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe EGFR Antibody Sales by Country (2021-2026) & (K Units) Table 138. Europe EGFR Antibody Sales Market Share by Country (2021-2026) Table 139. Europe EGFR Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe EGFR Antibody Sales Market Share Forecast by Country (2027-2032) Table 141. Europe EGFR Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe EGFR Antibody Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe EGFR Antibody Market Share by Country (2021-2026) Table 144. Europe EGFR Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe EGFR Antibody Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific EGFR Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific EGFR Antibody Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific EGFR Antibody Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific EGFR Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific EGFR Antibody Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific EGFR Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific EGFR Antibody Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific EGFR Antibody Market Share by Country (2021-2026) Table 154. Asia-Pacific EGFR Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific EGFR Antibody Market Share Forecast by Country (2027-2032) Table 156. Latin America EGFR Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America EGFR Antibody Sales by Country (2021-2026) & (K Units) Table 158. Latin America EGFR Antibody Sales Market Share by Country (2021-2026) Table 159. Latin America EGFR Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America EGFR Antibody Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America EGFR Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America EGFR Antibody Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America EGFR Antibody Market Share by Country (2021-2026) Table 164. Latin America EGFR Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America EGFR Antibody Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa EGFR Antibody Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa EGFR Antibody Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa EGFR Antibody Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa EGFR Antibody Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa EGFR Antibody Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa EGFR Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa EGFR Antibody Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa EGFR Antibody Market Share by Country (2021-2026) Table 174. Middle East and Africa EGFR Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa EGFR Antibody Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. EGFR Antibody Distributors List Table 179. EGFR Antibody Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. EGFR Antibody Image Figure 2. Global EGFR Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global EGFR Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global EGFR Antibody Sales (2021-2032) & (K Units) Figure 5. Polyclonal Image Figure 6. Global Polyclonal Sales YoY Growth (2021-2032) & (K Units) Figure 7. Monoclonal Image Figure 8. Global Monoclonal Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global EGFR Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global EGFR Antibody Market Share by Type 2025 VS 2032 Figure 11. North America EGFR Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America EGFR Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe EGFR Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe EGFR Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific EGFR Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific EGFR Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America EGFR Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America EGFR Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa EGFR Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa EGFR Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 EGFR Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Immunohistochemistry Image Figure 24. Global Immunohistochemistry Sales YoY Growth (2021-2032) & (K Units) Figure 25. Immunofluorescence Image Figure 26. Global Immunofluorescence Sales YoY Growth (2021-2032) & (K Units) Figure 27. Enzyme Linked Immunosorbent Assay Image Figure 28. Global Enzyme Linked Immunosorbent Assay Sales YoY Growth (2021-2032) & (K Units) Figure 29. Flow Cytometry Image Figure 30. Global Flow Cytometry Sales YoY Growth (2021-2032) & (K Units) Figure 31. Western Blot Image Figure 32. Global Western Blot Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global EGFR Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global EGFR Antibody Market Share by Application 2025 VS 2032 Figure 37. North America EGFR Antibody Sales Market Share in Volume by Application in 2025 Figure 38. North America EGFR Antibody Sales Market Share in Value by Application in 2025 Figure 39. Europe EGFR Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Europe EGFR Antibody Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific EGFR Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific EGFR Antibody Sales Market Share in Value by Application in 2025 Figure 43. Latin America EGFR Antibody Sales Market Share in Volume by Application in 2025 Figure 44. Latin America EGFR Antibody Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa EGFR Antibody Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa EGFR Antibody Sales Market Share in Value by Application in 2025 Figure 47. North America EGFR Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America EGFR Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America EGFR Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe EGFR Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe EGFR Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe EGFR Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific EGFR Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific EGFR Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific EGFR Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America EGFR Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America EGFR Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America EGFR Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa EGFR Antibody Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa EGFR Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa EGFR Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa EGFR Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. EGFR Antibody Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. EGFR Antibody Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Immunohistochemistry
  • Immunofluorescence
  • Enzyme Linked Immunosorbent Assay
  • Flow Cytometry
  • Western Blot
  • Others
Companies covered
  • Atlas Antibodies
  • Bethyl
  • Bio X Cell
  • BioLegend
  • Bio-Rad
  • Everest Biotech
  • EXBIO
  • FineTest
  • Miltenyi Biotec
  • Santa Cruz Biotechnology
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global EGFR Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global EGFR Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 EGFR Antibody Market by Type
  6. 1.3.1 Polyclonal
  7. 1.3.2 Monoclonal
  8. 1.4 Global EGFR Antibody Market Size by Type
  9. 1.4.1 Global EGFR Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global EGFR Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global EGFR Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America EGFR Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe EGFR Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific EGFR Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America EGFR Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa EGFR Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 EGFR Antibody Industry Trends
  2. 2.2 EGFR Antibody Industry Drivers
  3. 2.3 EGFR Antibody Industry Opportunities and Challenges
  4. 2.4 EGFR Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by EGFR Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by EGFR Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by EGFR Antibody Price (2021-2026)
  4. 3.4 Global EGFR Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global EGFR Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global EGFR Antibody Company, Product Type & Application
  7. 3.7 Global EGFR Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global EGFR Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 EGFR Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 EGFR Antibody Tier 1, Tier 2, and Tier 3
4 EGFR Antibody Regional Status and Outlook
  1. 4.1 Global EGFR Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global EGFR Antibody Historic Market Size by Region
  3. 4.2.1 Global EGFR Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global EGFR Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global EGFR Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global EGFR Antibody Forecasted Market Size by Region
  7. 4.3.1 Global EGFR Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global EGFR Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global EGFR Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 EGFR Antibody by Application
  1. 5.1 EGFR Antibody Market by Application
  2. 5.1.1 Immunohistochemistry
  3. 5.1.2 Immunofluorescence
  4. 5.1.3 Enzyme Linked Immunosorbent Assay
  5. 5.1.4 Flow Cytometry
  6. 5.1.5 Western Blot
  7. 5.1.6 Others
  8. 5.2 Global EGFR Antibody Market Size by Application
  9. 5.2.1 Global EGFR Antibody Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global EGFR Antibody Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global EGFR Antibody Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America EGFR Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe EGFR Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific EGFR Antibody Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America EGFR Antibody Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa EGFR Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Atlas Antibodies
  2. 6.1.1 Atlas Antibodies Company Information
  3. 6.1.2 Atlas Antibodies Business Overview
  4. 6.1.3 Atlas Antibodies EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Atlas Antibodies EGFR Antibody Product Portfolio
  6. 6.1.5 Atlas Antibodies Recent Developments
  7. 6.2 Bethyl
  8. 6.2.1 Bethyl Company Information
  9. 6.2.2 Bethyl Business Overview
  10. 6.2.3 Bethyl EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bethyl EGFR Antibody Product Portfolio
  12. 6.2.5 Bethyl Recent Developments
  13. 6.3 Bio X Cell
  14. 6.3.1 Bio X Cell Company Information
  15. 6.3.2 Bio X Cell Business Overview
  16. 6.3.3 Bio X Cell EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bio X Cell EGFR Antibody Product Portfolio
  18. 6.3.5 Bio X Cell Recent Developments
  19. 6.4 BioLegend
  20. 6.4.1 BioLegend Company Information
  21. 6.4.2 BioLegend Business Overview
  22. 6.4.3 BioLegend EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BioLegend EGFR Antibody Product Portfolio
  24. 6.4.5 BioLegend Recent Developments
  25. 6.5 Bio-Rad
  26. 6.5.1 Bio-Rad Company Information
  27. 6.5.2 Bio-Rad Business Overview
  28. 6.5.3 Bio-Rad EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bio-Rad EGFR Antibody Product Portfolio
  30. 6.5.5 Bio-Rad Recent Developments
  31. 6.6 Everest Biotech
  32. 6.6.1 Everest Biotech Company Information
  33. 6.6.2 Everest Biotech Business Overview
  34. 6.6.3 Everest Biotech EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Everest Biotech EGFR Antibody Product Portfolio
  36. 6.6.5 Everest Biotech Recent Developments
  37. 6.7 EXBIO
  38. 6.7.1 EXBIO Company Information
  39. 6.7.2 EXBIO Business Overview
  40. 6.7.3 EXBIO EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 EXBIO EGFR Antibody Product Portfolio
  42. 6.7.5 EXBIO Recent Developments
  43. 6.8 FineTest
  44. 6.8.1 FineTest Company Information
  45. 6.8.2 FineTest Business Overview
  46. 6.8.3 FineTest EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 FineTest EGFR Antibody Product Portfolio
  48. 6.8.5 FineTest Recent Developments
  49. 6.9 Miltenyi Biotec
  50. 6.9.1 Miltenyi Biotec Company Information
  51. 6.9.2 Miltenyi Biotec Business Overview
  52. 6.9.3 Miltenyi Biotec EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Miltenyi Biotec EGFR Antibody Product Portfolio
  54. 6.9.5 Miltenyi Biotec Recent Developments
  55. 6.10 Santa Cruz Biotechnology
  56. 6.10.1 Santa Cruz Biotechnology Company Information
  57. 6.10.2 Santa Cruz Biotechnology Business Overview
  58. 6.10.3 Santa Cruz Biotechnology EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Santa Cruz Biotechnology EGFR Antibody Product Portfolio
  60. 6.10.5 Santa Cruz Biotechnology Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck EGFR Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Merck EGFR Antibody Product Portfolio
  66. 6.11.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America EGFR Antibody Sales by Country
  2. 7.1.1 North America EGFR Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America EGFR Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America EGFR Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America EGFR Antibody Market Size by Country
  6. 7.2.1 North America EGFR Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America EGFR Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America EGFR Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe EGFR Antibody Sales by Country
  2. 8.1.1 Europe EGFR Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe EGFR Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe EGFR Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe EGFR Antibody Market Size by Country
  6. 8.2.1 Europe EGFR Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe EGFR Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe EGFR Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific EGFR Antibody Sales by Country
  2. 9.1.1 Asia-Pacific EGFR Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific EGFR Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific EGFR Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific EGFR Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific EGFR Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific EGFR Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific EGFR Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America EGFR Antibody Sales by Country
  2. 10.1.1 South America EGFR Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America EGFR Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America EGFR Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America EGFR Antibody Market Size by Country
  6. 10.2.1 South America EGFR Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America EGFR Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America EGFR Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa EGFR Antibody Sales by Country
  2. 11.1.1 Middle East and Africa EGFR Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa EGFR Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa EGFR Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa EGFR Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa EGFR Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa EGFR Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa EGFR Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 EGFR Antibody Value Chain Analysis
  2. 12.1.1 EGFR Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 EGFR Antibody Production Mode & Process
  7. 12.2 EGFR Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 EGFR Antibody Distributors
  10. 12.2.3 EGFR Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst